Ftse Mib
34.799,27
-0,83%
DAX
20.132,85
-0,44%
S&P 500
5.836,22
0,16%
NASDAQ
19.088,10
-0,38%
Bitcoin
94.927,53
0,44%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX BriaCell Therapeutics Corp (BCT) BriaCell Therapeutics Corp (BCT) Notizie

BriaCell Therapeutics Corp

BCT
0,56
-0,03 (-5,08%)
13 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: Toronto
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
17/12/202422:05GLOBEBriaCell Announces Availability of Annual General Meeting..
17/12/202422:05GLOBEBriaPro Therapeutics Corp. Announces Availability of Annual..
13/12/202422:05GLOBEBriaCell Therapeutics Announces Closing of $5.5 Million..
13/12/202413:50GLOBEBriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™..
12/12/202405:54GLOBEBriaCell Therapeutics Announces Pricing of $5.5 Million..
11/12/202422:05GLOBEBriaCell Therapeutics Announces Proposed Public Offering
11/12/202413:50GLOBEBriaCell Presents Unprecedented Overall Survival Data in..
02/12/202413:50GLOBEBriaCell Receives Green-Light from Data Safety Monitoring..
26/11/202413:50GLOBEBriaCell 2024 SABCS® Spotlight Poster to Showcase Positive..
25/11/202413:50GLOBEBriaCell Provides Update to its Board of Directors
21/11/202413:50GLOBEBriaCell Announces First Patient Dosed with Bria-OTS™ in..
08/11/202413:50GLOBEBriaCell Showcases Robust Anti-Cancer Activity of..
04/11/202413:50GLOBEBriaCell Overall Survival Data Selected for Spotlight Poster..
22/10/202413:50GLOBEBriaCell Reports Outperforming Metastatic Breast Cancer..
15/10/202413:50GLOBEBriaCell Provides Phase 3 Clinical Engagement Update in..
02/10/202422:05GLOBEBriaCell Therapeutics Announces Closing of $5 Million..
01/10/202420:05GLOBEBriaCell Therapeutics Announces $5 Million Offering
01/10/202413:50GLOBEBriaCell Reports 100% Resolution of Brain Metastasis in..
18/9/202413:50GLOBEBriaCell Announces FDA-Authorized Expanded Access Policy for..
12/9/202422:05GLOBEBriaCell Therapeutics Announces Closing of $8.5 Million..
11/9/202418:09GLOBEBriaCell Therapeutics Announces $8.5 Million Offering
11/9/202413:50GLOBEBriaCell Reports Positive Overall Survival (OS) in..
10/9/202413:50GLOBEBriaCell Announces Positive Pre-IND Meeting with FDA for..
09/9/202413:50GLOBEBriaCell Announces Presentation at the 2024 Society for..
18/7/202413:56GLOBEBriaCell Quadruples Progression Free Survival (PFS) in..
03/6/202414:00GLOBEBriaCell Presents Clinical Efficacy Data at ASCO 2024
30/5/202414:00GLOBEBriaCell Initiates Patient Enrollment in First-in-Human..
28/5/202414:00GLOBEBriaCell Announces Clinical Supply Agreement with BeiGene..
24/5/202414:00GLOBEBriaCell Doubles Progression-Free-Survival (PFS) and Reports..
17/5/202422:33GLOBEBriaCell Therapeutics Announces Closing of $5.0 Million..
15/5/202414:00GLOBEBriaCell Therapeutics Announces Pricing of $5.0 Million..
24/4/202414:00GLOBEBriaCell Announces Oral and Poster Presentations at ASCO..
10/4/202414:00GLOBEBriaCell 2024 AACR Preclinical Poster Confirms Strong..
09/4/202414:00GLOBEBriaCell Showcases Data Demonstrating Unmatched..
07/3/202414:00GLOBEBriaCell Receives and Executes Letter of Intent to Advance..
06/3/202414:00GLOBEBriaCell to Present Clinical Data in Central Nervous System..
27/2/202414:00GLOBEBriaCell Provides Update on Alleged Illegal Trading of..
07/2/202414:00GLOBEBriaCell Announces Strong Clinical Data in Breast Cancer..
06/2/202414:30GLOBEBreaking Ground in Prostate Cancer: BriaCell Announces Lead..
31/1/202404:48GLOBEBriaCell Therapeutics Corp. Announces Results of Shareholder..
Apertura: 0,60 Min: 0,55 Max: 0,60
Chiusura: 0,59

La tua Cronologia

TSX
BCT
BriaCell Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network